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systemic lupus erythematosus (sle) is an autoimmune inflammatory disease with involvement of multiple organs and the production of autoantibodies against 
different components of the cell and with different 
clinical manifestations.1,2 manifestations could be 
musculoskeletal, dermatologic, renal, cardiovascular, 
pulmonary, cardiac, hematologic, gastrointestinal, 
ocular, and neurologic.3 In a community-based study 
of rheumatic disease control, carried out by the Centre 
for rheumatology research, the prevalence of sle 
in Iran was estimated 40 per 100 000 individuals.4 
The incidence is eight-times higher in women than 
men.5 lifetime chronic stresses lead to physical and 
mental effects and, subsequently, decrease the quality 
of  life (Qol) of patients with sle.6
psychological therapies have been considered 
to reduce physical and mental complications. segal 
and colleagues7 developed mindfulness-based 
cognitive therapy (mbCt) to prevent recurrence 
of depression (within eight group sessions). This 
approach is based on the mindfulness-based stress 
reduction by Kabat-Zinn. This approach increases 
the flexibility of cognitive activity and rumination, 
decreases overgeneralization of biographical 
memory and self-critical evaluation, and increases 
useful cognitive processes. patients are encouraged 
to process an experience as it has already been 
developed and without judgment, and change 
their relationship with challenging thoughts and 
feelings and embrace them.7 The positive effect of 
this therapeutic approach on anxiety and mood 
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A B S T R AC T
Objectives: This study was conducted to determine the efficacy of mindfulness-based 
cognitive therapy (mbCt) on psychological symptoms and quality of life (Qol) 
in patients with systemic lupus erythematosus (sle). Methods: We conducted a 
randomized single-blind clinical trial in patients with sle referred from the Imam ali 
Clinic in shahrekord, southwest Iran. The patients (46 in total in two groups of 23 
each) were randomly assigned into the experimental and control groups. both groups 
underwent routine medical care, and the experimental group underwent eight group 
sessions of mbCt in addition to routine care. The patient,s Qol was assessed using the 
General Health Questionnaire-28 and 36-Item short Form Health survey before, after, 
and six months after intervention (follow-up). Results: a significant difference was seen 
in psychological symptoms and Qol between mbCt and control groups immediately 
after the intervention and at follow-up (p ≤ 0.050). However, the difference was not 
significant for the physical components of Qol (p ≥ 0.050). Conclusions: mbCt 
contributed to decreased psychological symptoms and improved Qol in patients with 
sle with a stable effect on psychological symptoms and psychological components of 
Qol, but an unstable effect on physical components.
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disorders, suicidal depression, chronic pain, cancer, 
and obsessive compulsive disorder (OCd) has been 
demonstrated.8–13 some research indicates that the 
use of a stress management program can contribute 
to reducing pain and stress and improving mental 
and physical performance in patients with sle.14 
navarrete-navarrete et al,15 investigated predictive 
factors of Qol in patients with sle and variations 
in them after cognitive-based therapy (Cbt). The 
results demonstrated a remarkable improvement in 
patients health-related Qol.15 In another study, the 
experimental group received 10 sessions of Cbt. 
the results demonstrated a significant reduction 
in daily stresses, anxiety, and depression. There was 
an improvement in Qol in the experimental group 
compared with the control group, but the reduction 
was not significant for the disease activity index.6 
Cognitive therapies are reported to be effective in 
treating many mental disorders.16–22 
Considering that mbCt is an interventional 
method to decrease psychological symptoms, patients 
learn to become aware of their body sensation, 
thoughts, and emotions without being judged. This 
decreases negative judgments and thoughts, which 
are the main causes of psychological symptoms and 
leads to their elimination.
most psychological interventions in people with 
sle have been designed for Western populations. to 
our knowledge, no study has examined the impact 
of mbCt on psychological symptoms and indices 
of Qol in patients with sle in Iran. This study was 
conducted to determine the efficacy of mbCt on 
psychological symptoms and Qol in patients with 
sle residing in shahrekord, Iran.
M ET H O D S
this was a single-blind randomized clinical trial 
study and was registered as IrCt201412018253n3 
in Iranian registry of Clinical trials.
a total of 46 patients with sle were assigned and 
selected to take part in the study (23 patients in the 
experimental group and 23 in the control group). 
patients with sle were enrolled according to the 
american College of rheumatology criteria23,24 from 
the rheumatology specialty Clinic of ayatollah 
Kashani Hospital of shahrekord, southwest Iran. 
The sampling method was based on convenience 
sampling because the data on the variability of the 
psychological symptoms were not available in both 
groups. The sample size was calculated based on a 
95% confidence level and a power of 90% to see a 
difference equal to one standard deviation (sd) of 
the mean psychological symptoms score between the 
two groups. 
a sample size of 21 patients in each group was 
calculated and raised to 23 to obtain more precision. 
Inclusion criteria consisted of meeting at least four 
american College of rheumatology diagnostic 
criteria, education to at least third grade of guidance 
school, and consenting to participate in the study. 
patients were excluded if they had a history of 
taking psychiatric medications and undergoing 
psychological therapies within the past six months. 
The follow-up lasted six months.
a trained clinical psychologist conducted 
mbCt. adherence to treatment was examined by 
the participants’ reports at the beginning of each 
session. In addition, a checklist was developed for 
the participants to self-record daily routines and 
home assignments. assessments were conducted by 
a trained psychometrics expert.
demographic data including age, gender, marital 
status, employment status, educational status, and 
disease history was collected for each patient. The 
patients were matched by demographic data and 
medical history. all the participants completed the 
study procedure.
The self-reported General Health Questionnaire 
(GHQ- 28), developed by Goldberg and Hiller, was 
used to distinguish between mental health and mental 
illness. GHQ-28 has four subscales: depression, 
anxiety, social function, and somatization. GHQ-28 
has satisfactory reliability and validity for many cross-
cultural populations, including Farsi speaking.25,26 
the 36-Item short Form Health survey (sF-
36)27 was used to assess Qol. It has two subscales; 
mental and physical. The scores range from 0 to 100 
and are directly proportional to health conditions; 
therefore, a higher score means a better Qol.28,29
after the participants were enrolled, they were 
randomly (random number table) assigned to one 
of two groups: mbCt and control. The used tests 
were run for both groups. both groups underwent 
routine medical care. In the experimental group, each 
participant individually underwent eight sessions 
(45–60 minutes) of mbCt. In addition to usual 
medical care, general advice was given to the control 
group on how to comply with the pharmaceutical 
and nutritional orders and get enough rest.
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The participants were required to do their mbCt 
assignments within 30 minutes of the session, at 
home. The control group, alongside routine medical 
treatments, received conventional recommendations 
such as moderate exercise, balanced diet, and 
sufficient rest. 
The content of mbCt sessions was developed 
per segal et al,7 manual. The main components of 
mbCt were formal meditation, yoga, and formal 
daily mindfulness practices [table 1]. The patients 
were assessed with the GHQ-28, sF-36 pre- and 
post-intervention, and six-month post-intervention 
(follow-up).
descriptive statistics were used to assess 
demographic characteristics and disease history. 
We used the Komogorov-smirnov test for assessing 
normal distribution of scores and levene’s test for 
assessing the equality of variances. For both Qol 
and psychological symptoms, the variances were 
equal, and the means were normal. Therefore, we 
could use covariance test. For continuous variables, 
data were presented as means±sd and categorical 
variables as frequency and percent. 
The normal distribution and equality of variances 
of the scores were evaluated and confirmed using 
one-sample Kolmogorov-smirnov and levene’s 
test, respectively. analysis of covariance was used 
to compare the scores of Qol and psychological 
symptoms between the two groups. 
statistical analysis was performed using spss 
statistics (spss Inc. released 2008. spss statistics for 
Windows, version 17.0. Chicago, Us) and p-values < 
0.050 were considered statistically significant.
R E SU LTS
The mean age of the participants in the mbCt and 
control groups was 38 and 40 years old, respectively. 
The disease history of 13 participants was < 4 years, 
5–8 years in 18 participants, 9–12 years in 10 
participants, and > 13 years in five participants. 
naturally, the longer the disease duration, the easier 
Table 1: Curriculum for sessions of mindfulness-based cognitive therapy.
Session 
number
Contents
1 establish orientation of the session and set the rules, raising exercise to train being in the present moment, body 
scan practice, breath focus exercise.
2 body scan practice, thought and feeling exercise, pleasant event calendar, mindfulness of routine activity.
3 seeing and hearing exercise, sitting meditation, three-minute breathing space, mindful walking, unpleasant event 
calendar.
4 seeing and hearing exercise, sitting meditation, defining the territory of depression, negative automatic thought, 
diagnosis criteria for depression.
5 sitting meditation, breathing space, reading poems related to mindfulness, introducing the concept of “acceptance”.
6 sitting meditation, mood, thoughts and alternative points exercise, breathing space, observing thoughts and feelings 
technique.
7 sitting meditation, exercise to explore links between activity and mood, behavioral activation (generate a list of 
pleasure and mastery activities), identifying actions to do in low-mood periods.
8 body scan practice, review the whole course, discuss how to keep up what has been developed over the past seven 
weeks, discuss plans and positive reasons for maintaining the practice.
Table 2: Participants’ characteristics at the 
beginning of the study.
Characteristics MBCT 
group
Control 
group
p-value
Age, mean ± SD, 
years
38.0 ± 13.6 40.0 ± 14.1 Ns
Gender
Male 8 (34.7) 7 (30.4) Ns
Female 15 (65.2) 16 (69.5) Ns
Education
Lower level 
vocational school
5 (21.7) 3 (13.0) Ns
Secondary and 
diploma education
Higher or 
university 
education
10 (43.4)
8 (34.7)
13 (56.5)
7 (30.4)
Ns
Ns
Disease duration, years
< 4 6 (26.0) 7 (30.4) Ns
5–8 10 (43.4) 8 (34.7) Ns
9–12 5 (21.7) 5 (21.7) Ns
> 13 2 (8.6) 3 (13.0) Ns
Employment
Employed 10 (43.7) 12 (52.1) Ns
Unemployed 13 (56.5) 11 (47.8) Ns
Data given as n(%) unless otherwise indicated.  
Ns: not significant; MBCT: mindfulness-based cognitive therapy;  
SD: standard deviation.
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the disease acceptance is and, therefore, the more 
difficult response to treatment. Fifteen participants 
in the mbCt group were women and eight 
were men. most participants in both groups had 
secondary and diploma level education, 56.5% of 
participants in the mbCt group were unemployed 
(mainly housewives) and this figure was 47.8% in the 
control group [table 2].
The mean score of psychological symptoms was 
57.5 in the mbCt group and 54.3 in the control 
group. a significant difference was obtained in the 
mean score of psychological symptoms between the 
mbCt and control group pre-intervention, post-
intervention, and at follow-up [table 3].
analysis of covariance indicated a significant 
difference in the mean score of psychological symptoms 
between the mbCt and control groups, both 
immediately after the treatment (F = 98.60; p < 0.001) 
and at follow-up (F = 79.41; p = 0.001). The effect size 
(eta) after the treatment was 0.78, meaning that 78.0% 
of the derived difference was due to mbCt [table 4]. 
The effects of mbCt on psychological symptoms were 
assessed by analysis of covariance immediately after 
treatment and at follow-up [table 4].
The mean Qol score was 43.7 in the mbCt group 
and 44.3 in the control group, with no significant 
difference. a significant difference was obtained 
in the mean score for psychological Qol between 
mbCt and control groups pre-intervention, post-
intervention, and at follow-up. For physical Qol, 
the mean score in the mbCt group increased after 
the intervention (49.7), but decreased at follow-up 
(45.6) [table 5].The effects of mbCt on Qol were 
assessed by analysis of covariance post-intervention 
and at follow-up [table 6].
analysis of covariance indicated a significant 
difference in the mean psychological Qol score 
between the mbCt group and the control group 
after the intervention (F = 968.97; p < 0.001) and 
in the follow-up (F = 66.39; p =0.004). The effect 
size immediately after therapy and at follow-up was 
0.46 and 0.32, respectively, meaning that 46.0% and 
32.0% of the derived difference between the two 
groups, respectively, was due to mbCt [table 6].
also, a significant difference in the mean score 
of physical Qol was derived between mbCt and 
control groups immediately after intervention 
(F = 473.22; p = 0.001) but not in the follow-up 
(F = 23.56; p = 0.157). The effect size in the follow-
up was 0.12, meaning that only 12.0% of the derived 
difference between the two groups was due to 
mbCt [table 6].
D I S C U S S I O N
The mean score of psychological symptoms decreased 
significantly in the mbCt group compared with the 
control group in the post-intervention and follow-
up periods. The findings indicate that mbCt could 
Table 3: Mean and standard deviation of scores on GHQ-28 and each subscales.
Measure Group Pre-treatment Post-treatment Follow-up
psychological symptoms (GHQ-28) mbCt 57.5 ± 9.7 37.2 ± 10.0 40.6 ± 8.8
CG 54.3 ± 7.4 57.3 ± 8.1 57.5 ± 9.5
depression mbCt 13.6 ± 4.1 8.9 ± 2.3 9.8 ± 3.1
CG 12.7 ± 2.5 14.4 ± 2.8 13.6 ± 2.4
anxiety mbCt 13.8 ± 4.2 9.2 ± 3.5 10.1 ± 3.2
CG 13.4 ± 3.2 14.5 ± 3.5 13.8 ± 3.1
social function mbCt 15.6 ± 3.5 8.8 ± 2.7 9.5 ± 2.9
CG 13.4 ± 3.7 14.7 ± 4.1 15.7 ± 4.3
somatization mbCt 14.4 ± 2.9 10.3 ± 2.3 11.2 ± 2.4
CG 14.7 ± 2.9 13.7 ± 3.2 14.3 ± 3.6
GHQ-28: general health questionnaire 28-item; MBCT: mindfulness-based cognitive therapy; CG: control group.
Table 4: Analysis of covariance of psychological 
symptoms outcomes post-treatment and follow-up.
Statistical 
test/
Source
df F p-value Eta 
squared
Observed 
power
pre-testa 1 37.40 0.001 0.49 0.95
treatmenta 1 98.60 < 0.001 0.78 0.97
pre-testb 1 22.80 0.009 0.27 0.88
treatmentb 1 79.41 0.001 0.38 0.94
a:post-treatment; b:follow-up; df: degrees of freedom.
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contribute positively to reducing psychological 
symptoms in patients with sle, which is consistent 
with a study performed by navarrete-navarrete et 
al.6 In their study, 45 patients with sle underwent 
10 sessions of Cbt and exhibited a significant 
decrease in daily stresses, anxiety, and depression 
and an improvement in Qol compared with the 
control group. However, little variation was seen in 
disease activity index. In another study, 122 patients 
with sle, accompanied by their spouses, underwent 
psychoeducational intervention for six months. 
Immediately after the intervention, there was a 
significant difference seen in the couples interactions 
and problem-solving skills, and at follow-up, there 
was a significant improvement in social support, 
self-efficacy, couples interactions, and daily chronic 
fatigue improved significantly,30 which is consistent 
with our findings. because psychological symptoms 
and problems are directly correlated with self-
efficacy, couples interactions, and daily chronic 
fatigue removal of the psychological symptoms leads 
to improvement of the other factors.
Other studies have demonstrated the efficacy of 
mbCt on pain tolerance in patients with low back 
pain,31 inability, pain, daily stresses in rheumatoid 
arthritis patients,32 depression symptoms in diabetes 
patients,33 OCd,13 and generalized anxiety disorder 
and panic.9,10 the results of these studies are 
consistent with our findings on the efficacy of this 
approach in reducing psychological symptoms in 
patients with sle.
We also found a significant difference in the 
psychological parameters of Qol between the 
mbCt and control groups both immediately after 
and at follow-up, but the difference in physical 
parameters of Qol was significant both immediately 
after and six-months after the intervention. 
bantornwan et al,34 followed-up 15 patients with 
sle for six months and compared them with the 
control group for Qol and normetanephrine use. 
the authors found no significant difference in 
normetanephrine use between the two groups, but 
the difference in psychological and physical Qol was 
significant.34 The results of their study are consistent 
with our findings on the psychological parameters of 
Qol. The inconsistency of the findings in the physical 
parameters can be attributed to the intervention and 
its duration. 
navarrete-navarrete et al,6 demonstrated that 
psychological interventions change psychological 
symptoms and Qol, but do not contribute to 
disease activity index. In their study, 45 patients were 
Table 5: Mean and standard deviation of the quality of life (QoL).
QoL (SF-36) Group Pre-intervention Post-intervention Follow-up
mCs mbCt 43.7 ± 11.0 51.6 ± 10.4 50.3 ± 11.8
CG 44.3 ± 10.8 43.7 ± 11.5 43.7 ± 12.4
pCs mbCt 44.0 ± 11.5 49.7 ± 10.6 45.6 ± 8.9
CG 43.2 ± 10.4 44.3 ± 11.7 44.8 ± 9.7
SF-36: short form 36-item health survey; MCS: mental component summary; PCS: physical component summary; MBCT: mindfulness-based cognitive therapy; 
CG: control group.
Table 6: Analysis of covariance of quality of life outcomes at post treatment.
Observed powerEta squaredp-valueFdfStatistical test/Source
Mental health
0.940.680.010153.421 Pre-testa
0.780.46< 0.001968.971 Treatmenta
0.890.420.001527.141 Pre-testb
0.820. 320.00466.391 Treatmentb
Physical function
0.910.720.000295.141 Pre-testa
0.840.380.001473.221 Treatmenta
0.870.540.010318.161 Pre-testb
0.910.120.15723.561 Treatmentb
a:post-treatment; b:follow-up; df: degrees of freedom.
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assigned to an experimental or control group; the 
experimental group received Cbt within 10 sessions. 
The results indicated a significant reduction in daily 
stresses, anxiety and depression, and improvement 
Qol in the experimental group compared with 
the control group. However, the reduction was 
not significant for disease activity index,6 which is 
consistent with our study. since Qol is associated 
with different factors (e.g., stress, anxiety, and 
depression), which can be reduced by Cbt, Qol 
can be improved. The predictive factors of Qol and 
the variation in them were examined in one study 
in patients with sle after Cbt.15 In agreement 
with our study, the authors found a remarkable 
improvement in patient’s health-related Qol. since 
patients with sle patients suffer from higher daily 
stress compared to the general population, which is 
associated with severity of sle symptoms,35,36 and 
psychiatric disorders, particularly mood and anxiety-
related, are highly prevalent in these patients.37 On 
the other hand, the disease is chronic and etiologically 
unknown,3 and patients with sle have a lower Qol 
compared with the general population.38,39 Given 
that previous studies showed that psychological 
interventions, especially Cbt, have positive effects 
on reducing stress and psychological problems as 
well as improving patient’s Qol,6,15 so it is assumed 
that mbCt can also be effective in improving Qol 
and reduce psychological symptoms. mbCt has 
been reported to be influential in reducing anxiety, 
depression, suicide in soldiers,40 reducing stress and 
improving the Qol in patients with breast cancer,41 
improving the Qol and decreasing the severity of 
symptoms in patients with psoriasis,42 and reducing 
the symptoms of patients with irritable bowel 
syndrome.43 Why the physical symptoms of Qol 
following intervention were not improved could be 
due to sle being a medical condition, and mbCt 
can only improve psychological consequences of the 
disease and while medical interventions are needed 
to treat the physical symptoms.
the generalizability of the results is limited. 
participants in this study may have completed 
the questionnaires with false information at post-
intervention or follow-up, and because these 
questionnaires lack a lie detector, the results should 
be generalized with caution. Judgment about the 
effectiveness of mbCt in the groups was made 
based on the test scores (GHQ-28 and Qol), which 
is a common method but clinical interview was 
not carried out to complete data on psychological 
symptoms and Qol in this study and, therefore, any 
generalization of the results should be conducted 
with caution. additionally, the small sample size may 
affect the results of the study. Of the strengths of this 
study is the psychological intervention; mbCt is a 
new intervention method among the other types of 
studies conducted.
C O N C LU S I O N
the findings of this study demonstrated that 
mbCt could improve patient’s Qol and relieve 
psychological symptoms in patients with sle, 
but was not effective in improving their physical 
symptoms because the main basis of treatment is 
medical. medical treatments are only effective to 
remove the physical symptoms of sle patients, 
and psychological interventions can only change 
their psychological outcomes although mental and 
physical problems interact in a complicated manner. 
Therefore, rheumatologists and psychologists are 
recommended to cooperate with each other to 
remove the psychological and physical symptoms of 
these patients.
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